.

Defense Digest

New Jersey Medical Provider Claims Are Contingent Upon Jurisdiction Over Underlying Claim

Defense Digest, Vol. 27, No. 1, January 2021

January 29, 2021

by Kiara K. Hartwell

Key Points:

  • For a New Jersey workers’ compensation court to have jurisdiction over Medical Provider claims, there must be jurisdiction over an underlying claim.
  • Jurisdiction can be determined by place of injury, place of contract, place of employment, place where industry is localized, place of residency, place decided on by a contract or place of sufficient contacts.
  • The Appellate Division cautions litigants against disrespectful characterizations of unfavorable decisions by workers’ compensation judges.

In a recently consolidated appeal, the New Jersey Appellate Division clarified the scope of jurisdiction granted to workers’ compensation courts in medical provider claims. The New Jersey Workers’ Compensation Act provides “[e]xclusive jurisdiction” to the courts over disputed medical charges “arising from any claim for compensation for a work-related injury or illness.” Although the jurisdiction inquiry is fact-sensitive, the Appellate Division went further to explain that a single day of treatment in New Jersey was insufficient without any other contacts.

In the first of the two consolidated cases, Anesthesia Assoc. of Morristown, PA v. Weinstein Supply Corp., 2020 WL 5944009 (N.J. Super. App. Div. Oct. 7, 2020), Anesthesia Assoc. of Morristown, PA provided services to an injured worker at a New Jersey hospital on March 22, 2018. The underlying workers’ compensation claim was filed in Pennsylvania because the accident occurred in Pennsylvania, the injured worker was a resident of Pennsylvania, and Weinstein Supply Corp. was based in Pennsylvania. Anesthesia Assoc. submitted a claim to the Pennsylvania Department of Labor and Industry and received a payment per the applicable fee schedule. It subsequently sought payment of the balance from Weinstein’s insurance carrier.

When Weinstein’s insurer failed to make payment on the balance, Anesthesia Assoc. filed a Medical Provider claim in New Jersey. Weinstein filed a motion to dismiss for lack of jurisdiction, which the New Jersey workers’ compensation court ultimately granted. In doing so, the court concluded it did not have personal jurisdiction over the underlying workers’ compensation claim because none of the “Larson factors” (found in Williams v. Port Auth. of N.Y. & N.J., 175 N.J. 82, 87-88 (2003)) applied:

[the employee] lived in [Pennsylvania], worked in [Pennsylvania], and the accident occurred in [Pennsylvania]. The contract of hire occurred in [Pennsylvania]. No contract exists between [Anesthesia Assoc.] and Weinstein. The only connection to New Jersey is that [the employee] underwent one day of medical treatment with [Anesthesia Assoc.] in New Jersey.

The court explained that, just as the courts have found an injured worker’s New Jersey residence alone was insufficient for jurisdiction, “one day of treatment in New Jersey” was also insufficient.

In the second case, Surgicare of Jersey City v. Waldbaums, 2020 WL 5944009 (N.J. Super. App. Div. Oct. 7, 2020), the injured worker, a resident of New York, was injured in New York while working for his New York employer, Stop & Shop. The worker filed a claim in New York and, on August 11, 2017, underwent surgery at Surgicare of Jersey City. Surgicare submitted a claim for payment in New York and subsequently filed a Medical Provider claim in New Jersey. Similar to Weinstein, Waldbaums filed a motion to dismiss for lack of jurisdiction. Surgicare argued that Waldbaums did business in New Jersey and that treatment was rendered in New Jersey, establishing jurisdiction there. However, the New Jersey workers’ compensation court granted Waldbaums’ motion, noting that the injured worker “was directed by his New York doctor to a surgical center in New Jersey for a single, one-day visit. The patient’s same-day surgery was performed by a New York doctor using equipment and devices ordered by the New York doctor.” The judge ruled that this single day of treatment was insufficient to “rise to the standard of sufficient purposeful minimal contacts” for personal jurisdiction.

In reviewing the consolidated appeals, the Appellate Division concluded that “[u]nless the Division [of Workers’ Compensation] has jurisdiction over the underlying claim for a compensable work-related injury, it does not have jurisdiction over a [Medical Provider claim] for payment.” After applying the six “Larson factors” to both cases, the Appellate Division agreed with the workers’ compensation courts in finding that no jurisdiction existed for either claim and held that both were appropriately dismissed.

Finally, feeling compelled to comment on various hyperbolic and inflammatory remarks in the appellants’ briefs, the Appellate Division cautioned against baseless, future attacks accusing the workers’ compensation judges of either abusing their authority or rendering incoherent or preposterous decisions. It was noted that such comments were unwarranted and did little to advance a client’s position, while, on the other hand, eroding the public’s trust in the judiciary.

As these cases illustrate, medical providers seeking reimbursement must establish jurisdiction over the underlying workers’ compensation claim. Although this is a fact-sensitive inquiry, these cases confirm that New Jersey workers’ compensation courts require, at the very least, more than a single day of treatment in New Jersey. The inquiry going forward will be whether two days of treatment or other similar examples will be sufficient bases for jurisdiction. In order to avoid any possibility of paying under the New Jersey payment scheme, where there is no set fee schedule, employers and carriers handling non-New Jersey claims should strive to direct care within their respective states as much as possible. This is not only because whether New Jersey has jurisdiction is fact-sensitive to each case, but also because New Jersey has no fee schedule and only pays the “usual and customary charges” for services.

*Kiara is an associate in our Mount Laurel, New Jersey office. She can be reached at (856) 414-6404 or kkhartwell@mdwcg.com.

Defense Digest, Vol. 27, No. 1, January 2021 is prepared by Marshall Dennehey Warner Coleman & Goggin to provide information on recent legal developments of interest to our readers. This publication is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. ATTORNEY ADVERTISING pursuant to New York RPC 7.1. © 2021 Marshall Dennehey Warner Coleman & Goggin. All Rights Reserved. This article may not be reprinted without the express written permission of our firm. For reprints, contact tamontemuro@mdwcg.com.

In a recently consolidated appeal, the New Jersey Appellate Division clarified the scope of jurisdiction granted to workers’ compensation courts in medical provider claims. The New Jersey Workers’ Compensation Act provides “[e]xclusive jurisdiction” to the courts over disputed medical charges “arising from any claim for compensation for a work-related injury or illness.” Although the jurisdiction inquiry is fact-sensitive, the Appellate Division went further to explain that a single day of treatment in New Jersey was insufficient without any other contacts.

In the first of the two consolidated cases, Anesthesia Assoc. of Morristown, PA v. Weinstein Supply Corp., 2020 WL 5944009 (N.J. Super. App. Div. Oct. 7, 2020), Anesthesia Assoc. of Morristown, PA provided services to an injured worker at a New Jersey hospital on March 22, 2018. The underlying workers’ compensation claim was filed in Pennsylvania because the accident occurred in Pennsylvania, the injured worker was a resident of Pennsylvania, and Weinstein Supply Corp. was based in Pennsylvania. Anesthesia Assoc. submitted a claim to the Pennsylvania Department of Labor and Industry and received a payment per the applicable fee schedule. It subsequently sought payment of the balance from Weinstein’s insurance carrier.

When Weinstein’s insurer failed to make payment on the balance, Anesthesia Assoc. filed a Medical Provider claim in New Jersey. Weinstein filed a motion to dismiss for lack of jurisdiction, which the New Jersey workers’ compensation court ultimately granted. In doing so, the court concluded it did not have personal jurisdiction over the underlying workers’ compensation claim because none of the “Larson factors” (found in Williams v. Port Auth. of N.Y. & N.J., 175 N.J. 82, 87-88 (2003)) applied:

[the employee] lived in [Pennsylvania], worked in [Pennsylvania], and the accident occurred in [Pennsylvania]. The contract of hire occurred in [Pennsylvania]. No contract exists between [Anesthesia Assoc.] and Weinstein. The only connection to New Jersey is that [the employee] underwent one day of medical treatment with [Anesthesia Assoc.] in New Jersey.

The court explained that, just as the courts have found an injured worker’s New Jersey residence alone was insufficient for jurisdiction, “one day of treatment in New Jersey” was also insufficient.

In the second case, Surgicare of Jersey City v. Waldbaums, 2020 WL 5944009 (N.J. Super. App. Div. Oct. 7, 2020), the injured worker, a resident of New York, was injured in New York while working for his New York employer, Stop & Shop. The worker filed a claim in New York and, on August 11, 2017, underwent surgery at Surgicare of Jersey City. Surgicare submitted a claim for payment in New York and subsequently filed a Medical Provider claim in New Jersey. Similar to Weinstein, Waldbaums filed a motion to dismiss for lack of jurisdiction. Surgicare argued that Waldbaums did business in New Jersey and that treatment was rendered in New Jersey, establishing jurisdiction there. However, the New Jersey workers’ compensation court granted Waldbaums’ motion, noting that the injured worker “was directed by his New York doctor to a surgical center in New Jersey for a single, one-day visit. The patient’s same-day surgery was performed by a New York doctor using equipment and devices ordered by the New York doctor.” The judge ruled that this single day of treatment was insufficient to “rise to the standard of sufficient purposeful minimal contacts” for personal jurisdiction.

In reviewing the consolidated appeals, the Appellate Division concluded that “[u]nless the Division [of Workers’ Compensation] has jurisdiction over the underlying claim for a compensable work-related injury, it does not have jurisdiction over a [Medical Provider claim] for payment.” After applying the six “Larson factors” to both cases, the Appellate Division agreed with the workers’ compensation courts in finding that no jurisdiction existed for either claim and held that both were appropriately dismissed.

Finally, feeling compelled to comment on various hyperbolic and inflammatory remarks in the appellants’ briefs, the Appellate Division cautioned against baseless, future attacks accusing the workers’ compensation judges of either abusing their authority or rendering incoherent or preposterous decisions. It was noted that such comments were unwarranted and did little to advance a client’s position, while, on the other hand, eroding the public’s trust in the judiciary.

As these cases illustrate, medical providers seeking reimbursement must establish jurisdiction over the underlying workers’ compensation claim. Although this is a fact-sensitive inquiry, these cases confirm that New Jersey workers’ compensation courts require, at the very least, more than a single day of treatment in New Jersey. The inquiry going forward will be whether two days of treatment or other similar examples will be sufficient bases for jurisdiction. In order to avoid any possibility of paying under the New Jersey payment scheme, where there is no set fee schedule, employers and carriers handling non-New Jersey claims should strive to direct care within their respective states as much as possible. This is not only because whether New Jersey has jurisdiction is fact-sensitive to each case, but also because New Jersey has no fee schedule and only pays the “usual and customary charges” for services.

*Kiara is an associate in our Mount Laurel, New Jersey office. She can be reached at (856) 414-6404 or kkhartwell@mdwcg.com.

Defense Digest, Vol. 27, No. 1, January 2021 is prepared by Marshall Dennehey Warner Coleman & Goggin to provide information on recent legal developments of interest to our readers. This publication is not intended to provide legal advice for a specific situation or to create an attorney-client relationship. ATTORNEY ADVERTISING pursuant to New York RPC 7.1. © 2021 Marshall Dennehey Warner Coleman & Goggin. All Rights Reserved. This article may not be reprinted without the express written permission of our firm. For reprints, contact tamontemuro@mdwcg.com.

Firm Highlights

Thought Leadership

New Jersey Expands Family Leave Protections Effective July 17, 2026

On January 17, 2026, Governor Murphy signed into law legislation expanding the New Jersey Family Leave Act (NJFLA). Beginning July 17, 2026, significant amendments to the NJFLA will expand job-protected family leave to smaller businesses and more employees across the state. The new law broadens coverage by lowering the threshold for private employers from 30 employees to 15 employees, meaning many smaller businesses will now be subject to the NJFLA. Employees of state and local government agencies will continue to be covered regardless of the size of the employer. The amendments also make it easier for employees to qualify for leave. Under the revised law, an employee will be eligible after three months of employment and at least 250 hours worked during the preceding 12 months, replacing the previous requirement of 12 months of employment and 1,000 hours worked. Currently, New Jersey's Temporary Disability Insurance (TDI) and Family Leave Insurance (FLI) programs provide eligible employees with wage replacement while they are on leave but do not independently guarantee job protection. The recent amendments to the New Jersey Family Leave Act (NJFLA) expand these protections by extending job-protected leave to additional employees. Under the amended law, employees receiving TDI or FLI benefits may be entitled to return to the same position they held before taking leave, or to an equivalent position with the same seniority, status, pay, and benefits. Although the legislation also states that it does not expand or modify an employee's reinstatement rights under the NJFLA, the amendments appear to provide job protection to eligible employees receiving TDI or FLI benefits without requiring them to separately satisfy the eligibility requirements of the NJFLA or the federal Family and Medical Leave Act (FMLA). As a result, some employees may be entitled to longer periods of job-protected leave than were previously available under existing law. With these amendments, New Jersey continues to strengthen workplace protections by expanding access to job-protected family leave for eligible employees. These changes significantly expand access to job-protected family leave and may require employers to update their leave policies, employee handbooks, and HR practices. Notably, employers who were previously not required to administer NJFLA may need to amend their policies and/or create new protocols to come into compliance with the NJFLA. Failure to do so would prove costly, as the penalties for non-compliance are significant.

Thought Leadership

Congress Passes Financial Exploitation Prevention Act

On June 25, 2026, the House passed the Financial Exploitation Prevention Act of 2025 (“the Act”) by a vote of 414 to 2. The Act allows financial advisors and firms to delay suspicious transactions regarding the accounts of clients who are 65 or older, if they believe financial exploitation has occurred or is about to take place. With the advancement of technology and AI, the House’s overwhelming bipartisan passage of the Financial Exploitation Prevention Act represents an important step in strengthening the financial industry’s ability to combat the growing threat of elder financial exploitation. The Act recognizes what advisors have long known that financial professionals are often the first to detect suspicious behavior but have historically lacked clear legal authority to intervene before irreversible financial harm occurs. From the industry’s perspective, the bill accomplishes several important objectives, including the following: (1) Provides a practical “pause button” by allowing financial professionals to temporarily delay certain transaction requests when there is a reasonable belief that a senior or vulnerable adult is being financially exploited; (2) Empowers financial professionals to act by providing greater certainty that firms can act in good faith to protect clients without unnecessary legal risk; and (3) Strengthens investor protection without sacrificing client rights by allowing temporary delays based on a reasonable suspicion of exploitation, which is intended only to allow additional review and not to deny clients access to their money indefinitely. In sum, the Financial Exploitation Prevention Act will equip financial professionals with practical, carefully tailored tools to stop suspected financial exploitation before client assets are lost. By allowing firms to temporarily delay suspicious transactions under defined circumstances, Congress is recognizing the critical role advisors play as the first line of defense against increasingly sophisticated fraud schemes. The Act strikes an appropriate balance between protecting vulnerable investors and preserving individual financial autonomy, while reinforcing collaboration among advisors, families, and law enforcement to combat financial exploitation. The bill now awaits Senate action.

Thought Leadership

SIU Gets a Boost: NJ Supreme Court Affirms Insurers' Right to Litigate, Not Arbitrate, Fraud Claims

In a significant win for insurers' Special Investigation Units, the New Jersey Supreme Court clarified that statutory insurance fraud and racketeering claims may proceed in court rather than through PIP arbitration. At issue was whether insurance fraud claims brought under New Jersey's Insurance Fraud Prevention Act (IFPA) and the state's Anti-Racketeering Act (NJ RICO) are subject to mandatory arbitration under the Automobile Insurance Cost Reduction Act’s (AICRA) PIP dispute-resolution framework. Allstate had sued a network of medical practices, physicians, and related corporate entities, alleging a scheme to extract more than $1.7 million in PIP benefits through fraudulent and misleading billing. The trial court dismissed Allstate's complaint and compelled arbitration, reading AICRA's arbitration clause — which covers "any dispute regarding the recovery of... benefits" under PIP coverage, N.J.S.A. 39:6A-5.1(a) — as sweeping in fraud and racketeering claims along with routine benefit disputes. The Supreme Court affirmed the Appellate Division's reversal, adopting Judge Gilson's opinion below (480 N.J. Super. 566 (App. Div. 2025)) as its own reasoning. The Court held that IFPA and RICO claims fall outside the scope of AICRA's PIP arbitration mechanism because that "streamlined and specialized" process cannot grant the relief those statutes contemplate — treble damages, injunctive relief, broad discovery, and joinder of third parties — and because arbitrators lack authority to award compensatory or treble damages to an insurer. The Court also rejected the argument that Allstate's own Decision Point Review Plans independently compel arbitration, finding those plan provisions no broader than AICRA's own arbitration clause. Notably, the Court expressly disagreed with the Third Circuit's contrary holding in GEICO v. Mt. Prospect Chiropractic Center, 98 F.4th 463 (3d Cir. 2024), concluding it is not bound by that federal interpretation of New Jersey law. Insurers retain the right to pursue IFPA and RICO claims in the Law Division, with a jury trial. For SIU units and NJ insurance carriers, this decision is a significant win: it forecloses defense clinics' primary procedural tool for shunting fraud investigations into limited-scope PIP arbitration, where treble damages, RICO relief, and meaningful discovery were never realistically available. Carriers building cases against fraudulently structured clinics, straw-owned practices, or coordinated billing networks can now proceed with confidence that a well-pleaded IFPA/RICO complaint stays in the Law Division rather than being diverted to arbitration on a motion to compel. Practically, this strengthens SIU's leverage in settlement negotiations, preserves civil discovery tools (subpoenas, depositions, joinder of related corporate entities) critical to unwinding complex ownership and referral schemes, and resolves the split with the Third Circuit in favor of NJ insurers — at least as a matter of state law. Expect increased reliance on IFPA civil actions, rather than PIP arbitration demands, as SIU's primary enforcement vehicle going forward.

Result

No-Cause Jury Verdict Secured in Wrongful Death Trial

We successfully obtained a no-cause jury verdict in a 13-day wrongful death trial. The decedent, a 59-year-old man, was admitted to the emergency room on February 15, 2019, with complaints of abdominal pain, decreased appetite, and constipation, despite the use of laxatives. The patient did not complain of any nausea, vomiting, or diarrhea. He had a significant medical history including diabetes, hypertension, prior coronary artery stenting, morbid obesity (with past gastric bypass surgery), longstanding ventral hernia, and back pain. A CT scan revealed multiple hernias and a potential closed-loop bowel obstruction, leading to a surgery consultation. Our client, an emergency general surgeon, interpreted that the patient did not have a closed loop or any significant obstruction and recommended non-surgical management. The patient was approved to have clear liquids, and had a vomiting incident shortly after, but our client was not notified. The patient was returned to NPO status, and after improving overnight, he was returned to “clears” and additional medical and renal consults were ordered. Our client did not receive any communications from the residents/nurses of any changes in the patient’s condition. On February 18, 2019, two rapid responses were called due to increased heart rate and vomiting. It is believed that the vomiting resulted in aspiration, causing sepsis, ultimately leading to the patient’s death. During the trial, the plaintiff’s sole medical expert highlighted imaging on the wrong hernia, which called into question all of his opinions in the case. We made key objections related to the expert testimony, limiting what the allegations were, and preventing new allegations from being made. After approximately two and a half hours of deliberating, the jury returned a no-cause verdict.